Drug Name Eylea Aflibercept Drug Class Hematopoietic growth factor Risk minimization type Healthcare provider guide patient guide Specialty (Theraputic area) Ophthalmology Risk • Endophthalmitis (likely infectious origin) • Intraocular inflammation • Transient intraocular pressure increase • Retinal pigment epithelial tears • Cataract (especially of traumatic originMedication errors • misuse • Embryo-fetotoxicity patient guide Health care provider guide